I’ve noticed a fair bit of weakness in my portfolio so far, and wanted to record all my recent transactions here.
Portfolio Update
Alex Rand invests • AR/i
Notes on a small investment portfolio
Category: Investments
Avacta – the next Roche?
The Affimer platform has proven to be outstanding inside the laboratory. Avacta could be a titan in the making. That’s for sure.
Bought – Omega Diagnostics
Their tests will likely develop significant revenues in the years to come – Covid is here to stay unfortunately. The current share price does not reflect this, and if they win the government contracts to manufacture LFTs, I expect it to rocket.
Bought – Power Metal Resources
Power Metal Resources appeals due to its diverse portfolio of exploration projects and frequent communications to investors.
Sold – EQTEC
After a steady decline in the SP since the new year, I have taken the decision to sell my remaining shares at 1.96p
Bought – Armadale Capital
This is an investment company, with its primary focus on the ‘Mahenge Graphite Project’.
Bought – Global Petroleum
Their main license is an area of oil exploration off the Namibian coast. This is a hot spot for oil explorers right now, and they neighbour areas licensed to Exxon Mobil.
Bought: 4d Pharma
The risk with any pharma company is that the product fails during R&D. Having this many products significantly mitigates against that risk.
Sold: N4 Pharma
I can foresee the share price falling further in the short term. I may open a position again when Nuvec is further along in development.
Bought: SIMEC Atlantis Energy
Given the increasing demand for green-energy, there are surely government contracts to be won. Simec Atlantis seems well placed to win these.